4.7 Article

Insufficient Evidence for Autism-Specific Genes

期刊

AMERICAN JOURNAL OF HUMAN GENETICS
卷 106, 期 5, 页码 587-595

出版社

CELL PRESS
DOI: 10.1016/j.ajhg.2020.04.004

关键词

-

资金

  1. National Institute of Mental Health (NIMH)
  2. Eunice Kennedy Shriver National Institute of Child Health and Human Development of the US National Institutes of Health (NIH) [R01MH074090, R01MH107431, U01MH11970510]
  3. Institut Pasteur, Universite de Paris, Fondation BettencourtSchueller
  4. Simons Foundation Autism Research Initiative
  5. Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54 HD087011]
  6. NIH [MH101221, U41 HG006834]
  7. Canadian Institute of Health Research Canada Research Chair, Canadian Institute of Health [400528]
  8. NIMH [U01 MH119690-01]

向作者/读者索取更多资源

Despite evidence that deleterious variants in the same genes are implicated across multiple neurodevelopmental and neuropsychiatric disorders, there has been considerable interest in identifying genes that, when mutated, confer risk that is largely specific for autism spectrum disorder (ASD). Here, we review the findings and limitations of recent efforts to identify relatively autism-specific genes, efforts which focus on rare variants of large effect size that are thought to account for the observed phenotypes. We present a divergent interpretation of published evidence; discuss practical and theoretical issues related to studying the relationships between rare, large-effect deleterious variants and neurodevelopmental phenotypes; and describe potential future directions of this research. We argue that there is currently insufficient evidence to establish meaningful ASD specificity of any genes based on large-effect rare-variant data.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据